Related Experiment Video
Updated: Apr 9, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Screening Active Compounds from Garcinia Species Native to China Reveals Novel Compounds Targeting the STAT/JAK
Linfeng Xu1, Yuanzhi Lao2, Yanhui Zhao3
1School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China ; Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai 201203, China ; Cell Biology Group of Shanghai Chempartner Ltd, Shanghai 201203, China.
Abstract:
Natural compounds from medicinal plants are important resources for drug development. In a panel of human tumor cells, we screened a library of the natural products from Garcinia species which have anticancer potential to identify new potential therapeutic leads and discovered that caged xanthones were highly effective at suppressing multiple cancer cell lines. Their anticancer activities mainly depended on apoptosis pathways. For compounds in sensitive cancer line, their mechanisms of mode of action were evaluated. 33-Hydroxyepigambogic acid and 35-hydroxyepigambogic acid exhibited about 1 μM IC50 values against JAK2/JAK3 kinases and less than 1 μM IC50 values against NCI-H1650 cell which autocrined IL-6. Thus these two compounds provided a new antitumor molecular scaffold. Our report describes 33-hydroxyepigambogic acid and 35-hydroxyepigambogic acid that inhibited NCI-H1650 cell growth by suppressing constitutive STAT3 activation via direct inhibition of JAK kinase activity.
Related Concept Videos
The JAK-STAT Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Amplifying Signals via Enzymatic Cascade